Entheon Biomedical Corp. (CSE:ENBI)
Canada · Delayed Price · Currency is CAD 0.1000
0.00 (0.00%)
Dec 18, 2025, 3:06 PM EST
Entheon Biomedical Market Cap
Entheon Biomedical has a market cap or net worth of CAD 1.39 million as of February 10, 2026. Its market cap has increased by 134.54% in one year.
Market Cap
1.39M
Enterprise Value
1.00M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since November 12, 2020, Entheon Biomedical's market cap has decreased from 24.64M to 1.39M, a decrease of -94.37%. That is a compound annual growth rate of -43.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 1.39M | -15.44% |
| Dec 30, 2024 | 1.64M | 177.36% |
| Dec 29, 2023 | 590.89K | -50.00% |
| Dec 30, 2022 | 1.18M | -93.85% |
| Dec 31, 2021 | 19.20M | -55.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gemina Laboratories | 4.59M |
| XORTX Therapeutics | 4.04M |
| MindBio Therapeutics | 3.84M |
| Rakovina Therapeutics | 3.60M |
| Appili Therapeutics | 3.21M |
| ASEP Medical Holdings | 3.00M |
| Algernon Health | 2.36M |
| Nirvana Life Sciences | 1.60M |